We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

128 hedge funds and large institutions have $182M invested in MacroGenics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 19

11% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 37

3% more funds holding

Funds holding: 124 → 128 (+4)

0.56% more ownership

Funds ownership: 88.89% → 89.45% (+0.56%)

3% less capital invested

Capital invested by funds: $188M → $182M (-$5.41M)

73% less call options, than puts

Call options by funds: $174K | Put options by funds: $644K

Holders
128
Holders Change
+4
Holders Change %
+3.23%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
41
Reduced
37
Closed
19
Calls
$174K
Puts
$644K
Net Calls
-$470K
Net Calls Change
-$792K

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$3.43M
2
SSA
Schonfeld Strategic Advisors
New York
+$3.09M
3
Morgan Stanley
Morgan Stanley
New York
+$2.83M
4
JP Morgan Chase
JP Morgan Chase
New York
+$799K
5
Renaissance Technologies
Renaissance Technologies
New York
+$793K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.77M
2
Millennium Management
Millennium Management
New York
-$2.42M
3
VPC
Vestal Point Capital
New York
-$1.98M
4
BlackRock
BlackRock
New York
-$1.25M
5
PA
Pinnacle Associates
New York
-$670K
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
$1.36M – – –
Marshall Wace
27
Marshall Wace
United Kingdom
$1.28M +$44.1K +12,250 +3%
Goldman Sachs
28
Goldman Sachs
New York
$1.14M +$442K +122,690 +54%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$1.05M +$60.2K +16,717 +5%
AQR Capital Management
30
AQR Capital Management
Connecticut
$1.04M -$377K -104,546 -25%
VPC
31
Vestal Point Capital
New York
$910K -$1.98M -550,000 -66%
PAM
32
Panagora Asset Management
Massachusetts
$831K -$357K -99,090 -28%
GCP
33
GSA Capital Partners
United Kingdom
$801K +$139K +38,727 +19%
TCM
34
Tang Capital Management
California
$711K – – –
Bank of America
35
Bank of America
North Carolina
$654K +$213K +59,005 +42%
N
36
Nuveen
North Carolina
$645K – – –
WP
37
Woodline Partners
California
$613K – – –
Fidelity Investments
38
Fidelity Investments
Massachusetts
$567K +$134K +37,281 +27%
UBS Group
39
UBS Group
Switzerland
$552K +$302K +83,947 +98%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$540K -$189K -52,439 -24%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$393K -$908 -252 -0.2%
CSS
42
Cubist Systematic Strategies
Connecticut
$364K +$403K +111,993 New
Barclays
43
Barclays
United Kingdom
$364K +$47.3K +13,138 +13%
SO
44
STRS Ohio
Ohio
$362K +$156K +43,400 +64%
BCM
45
Bridgeway Capital Management
Texas
$338K +$375K +104,000 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$334K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$302K +$7.49K +2,080 +2%
SFI
48
Susquehanna Fundamental Investments
Pennsylvania
$290K +$321K +89,134 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$277K +$9.19K +2,550 +3%
IC
50
Ikarian Capital
Texas
$260K -$29 -8 -0%
1
2
3 4 5

MGNX Hedge Fund Activity: Q4 2024 in Review

128 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2024, worth a combined $182M — down 2.9% from $188M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new MGNX positions and 19 closed out — a net gain of 4 holders — while 41 added to existing stakes and 37 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $3.43M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.77M.

  • 128 institutional investors held MacroGenics (MGNX) as of Q4 2024, up from 124 in Q3 2024.
  • Funds reported $182M of MacroGenics stock for Q4 2024, down 2.9% quarter-over-quarter.
  • 23 funds opened new MacroGenics positions in Q4 2024 and 19 closed out, a net change of +4 holders.
  • The largest MacroGenics buyer in Q4 2024 was Wasatch Advisors, an estimated $3.43M added.
  • The largest MacroGenics seller in Q4 2024 was T. Rowe Price Associates, an estimated $2.77M sold.

Based on aggregated 13F filings for Q4 2024.